Mounjaro, the brand name for tirzepatide, is making waves in the UK as a groundbreaking treatment for obesity and type 2 diabetes. Approved by the Medicines and Healthcare products Regulatory Agency (MHRA) in November 2023, Mounjaro offers a new avenue for weight management, particularly for adults with a body mass index (BMI) of 30 or more, or […]
